| (19) |
 |
|
(11) |
EP 3 771 719 A8 |
| (12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
Note: Bibliography reflects the latest situation |
| (15) |
Correction information: |
|
Corrected version no 1 (W1 A1) |
| (48) |
Corrigendum issued on: |
|
14.04.2021 Bulletin 2021/15 |
| (43) |
Date of publication: |
|
03.02.2021 Bulletin 2021/05 |
| (22) |
Date of filing: 02.08.2019 |
|
| (51) |
International Patent Classification (IPC):
|
|
| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA ME |
|
Designated Validation States: |
|
KH MA MD TN |
| (71) |
Applicant: Hochschule für angewandte Wissenschaften Coburg |
|
96450 Coburg (DE) |
|
| (72) |
Inventors: |
|
- Funke, Susanne Aileen
96242 Sonnefeld (DE)
- Malhis, Marwa
96450 Coburg (DE)
|
| (74) |
Representative: Engelhard, Markus |
|
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München
80336 München (DE) |
|
| |
|
| (54) |
A PEPTIDE BINDING TO TAU-PROTEIN |
(57) The present invention relates to peptides binding to tau-protein, and to a pharmaceutical
composition comprising such peptide(s). Furthermore, the present invention relates
to uses of such peptide(s) and pharmaceutical composition. Moreover, the present invention
relates to a kit comprising such peptide.